Hologic HOLX introduced its Q1 earnings on Wednesday, February 5, 2025 at 04:01 PM.
Here is a breakdown of the earnings report.
Earnings
Hologic beat estimated earnings by 1.0%, reporting an EPS of $1.03 versus an estimate of $1.02.
Income was up $9.00 million from the identical interval final 12 months.
Efficiency in Earlier Earnings
Through the earlier quarter, the corporate missed on EPS by $0.0, resulting in a 6.0% drop share worth change the following day.
Here is a take a look at Hologic’s previous efficiency:
Quarter | This autumn 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
EPS Estimate | 1.01 | 1.02 | 0.98 | 0.95 |
EPS Precise | 1.01 | 1.06 | 1.03 | 0.98 |
Income Estimate | 976.69M | 1.00B | 1.00B | 986.12M |
Income Precise | 987.90M | 1.01B | 1.02B | 1.01B |
New buyers ought to observe that it’s typically not an earnings beat or miss that the majority impacts the value of a inventory, however the steering (or forecast).
Steerage
Hologic administration supplied steering for Q2 2025, anticipating earnings between $1.0 and $1.03 per share.
To trace all earnings releases for Hologic go to their earnings calendar right here.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Overview Score:
Speculative
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.